Compounds > n-methylacetamide-oxotremorine m
Page last updated: 2024-08-22

n-methylacetamide-oxotremorine m and Coronary Disease

n-methylacetamide-oxotremorine m has been researched along with Coronary Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
MAASSEN, JH1
BARGHEER, R; FIEGEL, G; KELLING, HW; KUKWA, D1

Other Studies

2 other study(ies) available for n-methylacetamide-oxotremorine m and Coronary Disease

ArticleYear
[On the treatment of coronary heart disease with a selective, long-acting substance, 3-(2-diethylaminoethyl)-4-methyl-7-carbethoxymethoxy-2-oxo-1,2-chromene].
    Medizinische Klinik, 1963, Aug-02, Volume: 58

    Topics: Benzopyrans; Coronary Artery Disease; Coronary Disease; Humans; Oxotremorine; Vasodilator Agents

1963
[Protracted coronary vasodilator effect of 3-(2-diethylaminoethyl)-4-methyl-7-carbethoxy-methoxy-2-oxo-1.2-chromene].
    Die Medizinische Welt, 1963, Apr-27, Volume: 17

    Topics: Benzopyrans; Coronary Disease; Humans; Oxotremorine; Vasodilator Agents

1963